Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
This study is not yet open for participant recruitment.
Verified April 2013 by Medical College of Wisconsin
Sponsor:
Medical College of Wisconsin
Information provided by (Responsible Party):
Kathryn A Bylow, MD, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT01607879
First received: April 20, 2012
Last updated: April 19, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | October 2014 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |